🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchSo when is the pill version actually coming? Tired of needles — looking for input Page 3

So when is the pill version actually coming? Tired of needles — looking for input

RegAffairsDC Mon, Dec 22, 2025 at 6:35 PM 12 replies 1,142 viewsPage 3 of 3
DanielChem_CHI
Senior Member
1,234
5,678
Mar 2024
Chicago, IL
Dec 25, 2025 at 11:01 AM#11
pete_nash said:
It is worth asking what the claim would look like if it were false.

That is right, and it stops being right at the edges. The general case is well behaved; the interesting cases in this thread are all at the boundary where the general case breaks.

20 18fiona_VT, denise_HTX, raj_cambridge and 17 others
Reply Quote Save Share Report
jason_sac26
New Member
34
123
Jan 2026
Sacramento, CA
Dec 27, 2025 at 2:15 PM#12
PharmD_Rodriguez said:
Agreed, with the usual condition: that holds for the average and this board is a collection of individuals.

Genuinely useful, thank you. I had the facts and not the framework.

21 19Dr.EM_Chicago, pete_RVA, CarlaRPh_TPA and 18 others
Reply Quote Save Share Report
Dr.BariatricHTX
Senior Member
1,456
7,234
Feb 2024
Houston, TX
Dec 29, 2025 at 5:27 PM#13
pete_nash said:
It is worth asking what the claim would look like if it were false.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. Pushing back on the anecdote-stacking. Twenty people reporting the same thing is twenty samples from the same self-selected pool, not twenty independent confirmations.

22 20Dr.EM_Chicago, pete_RVA, CarlaRPh_TPA and 19 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
Dr.NateNeph
VIP Member
2,987
16,234
Dec 2023
Houston, TX
Dec 31, 2025 at 8:38 PM#14

The figures, for anyone assembling their own picture. Say what you would expect to see if you were wrong, before you look. It is a small discipline and it changes what you notice.

I would rather be corrected than agreed with, if it comes to it.

Last edited: Dec 31, 2025 at 10:38 PM
23 21B12Beth, RickReta_CO, PharmHunterJen and 20 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jan 2, 2026 at 11:48 PM#15

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part. Carry on.

24 22PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 21 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register